Coping with malaria in the face of resistance

International Journal of Infectious Diseases

Volumn 6, Issue 4, 2002, Pages 246-252

  Winstanley, Peter ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE; ARTEMETHER; ARTEMETHER PLUS BENFLUMETOL; ARTESUNATE; ATOVAQUONE PLUS PROGUANIL; CHLOROQUINE; CHLORPROGUANIL; CLINDAMYCIN; DAPSONE; FANSIDAR; INSECTICIDE; MEFLOQUINE; PYRETHROID; QUININE; TETRACYCLINE;

ANEMIA; BED NET; BRAIN MALARIA; CHEMOPROPHYLAXIS; COST EFFECTIVENESS ANALYSIS; DISEASE TRANSMISSION; DRUG APPROVAL; DRUG COST; DRUG EFFECT; DRUG EFFICACY; DRUG ELIMINATION; DRUG TOLERANCE; HEART ARRHYTHMIA; HUMAN; INFECTION PREVENTION; MALARIA; MICROBIAL BIOMASS; MORBIDITY; MORTALITY; PLASMODIUM FALCIPARUM; REVIEW; SHOCK; TREATMENT FAILURE;

EID: 0036926742     PISSN: 12019712     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1201-9712(02)90156-6     Document Type: Review

References (30)

1. Snow RW, Craig MH, Deichmann U, Marsh K. Estimating mortality, morbidity and disability due to malaria among Africa's non-pregnant population. Bull WHO 1999; 77: 624-640.
2. Nevill CG, Some ES, Mung'ala VO, et al. Insecticide-treated bednets reduce mortality and severe morbidity from malaria among children on the Kenyan coast. Trop Med Int Health 1996; 1(2):139-146.
3. Ter Kuile F. Effect of permethrin-impregnated bed nets on child morbidity and pregnancy in an area of intense perennial malaria transmission. In: 50th Annual Meeting, American Society of Tropical Medicine and Hygiene, Atlanta, 2001. Symposium 13.
4. Schellenberg JR, Abdulla S, Nathan R, et al. Effect of large-scale social marketing of insecticide-treated nets on child survival in rural Tanzania. Lancet 2001; 357(9264): 1241-1247.
5. Brabin BJ, Hakimi M, Pelletier D. An analysis of anemia and pregnancy-related maternal mortality. J Nutr 2001; 131(2S-2):604S-614S; discussion 614S-615S.
6. Shulman CE, Dorman EK, Cutts F, et al. Intermittent sulphadoxine-pyrimethamine to prevent severe anaemia secondary to malaria in pregnancy: A randomised placebo-controlled trial. Lancet 1999; 353(9153):632-636.
7. Schellenberg D, Menendez C, Kahigwa E, et al. Intermittent treatment for malaria and anaemia control at time of routine vaccinations in Tanzanian infants: A randomised, placebo-controlled trial. Lancet 2001; 357(9267):1471-1477.
8. Marsh VM, Mutemi WM, Muturi J, et al. Changing home treatment of childhood fevers by training shop keepers in rural Kenya. Trop Med Int Health 1999; 4(5):383-389.
9. Staedke SG, Kamya MR, Dorsey G, et al. Amodiaquine, sulfadoxine/pyrimethamine, and combination therapy for treatment of uncomplicated falciparum malaria in Kampala, Uganda: A randomised trial. Lancet 2001; 358(9279): 368-374.
10. Kublin JG, Dzinjalamala F, Kamwendo D, et al. Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria. J Infect Dis 2002; 185(3):380-388.
11. Muttabingwa TK, Kilama E, Winstanley P, Watkins W. Treatment and re-treatment of Plasmodium falciparum infections with pyrimethamine-sulfadoxine (PSD): A study to predict the useful therapeutic life of PSD as therapy for non-severe falciparum malaria in east Africa. Lancet 2001; 358:1218-1223.
12. Amukoye E, Winstanley PA, Watkins WM, et al. Chlorproguanil-dapsone: An effective treatment for uncomplicated falciparum malaria. Antimicrob Agents Chemother 1997; 41:2261-2264.
13. Nzila A, Nduati E, Mberu E, et al. Molecular evidence of greater selective pressure for drug resistance exerted by the long acting antifolate pyrimethamine/sulfadoxine compared with the shorter acting chlorproguanil-dapsone on Kenyan Plasmodium falciparum. J Infect Dis 2000; 181(6):2023-2028.
14. Winstanley PA, Watkins WM, Muhia D, Szwandt S, Amukoye E, Marsh K. Chlorproguanil-dapsone for uncomplicated falciparum malaria in young children: Pharmacokinetics and therapeutic range. Trans R Soc Trop Med Hyg 1997;91:322-327.
15. Ward SA, Manyando C, Horton J, Stubbs T, Winstanley PA. The pharmacokinetics ph arm acokine tics of Lapdap in man [abstract 576]. In: 50th Annual Meeting, American Society of Tropical Medicine and Hygiene, Atlanta, 2001.
16. White NJ. Delaying antimalarial drug resistance with combination chemotherapy. Parasitologia 1999; 41(1-3):301-308.
17. Nosten F, van Vugt M, Price R, et al. Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: A prospective study. Lancet 2000; 356 (9226):297-302.
18. Anonymous. The anti-malaria joint venture. http://www. foundation.novartis.com/malaria_riamet_china.htm
19. Trape JF, Pison G, Preziosi MP, et al. Impact of chloroquine resistance on malaria mortality. CR Acad Sci Ser 3 1998; 321:689-697.
20. World Health Organization. Severe falciparum malaria. Trans R Soc Trop Med Hyg 2000; 94(suppl 1).
21. Supanaranond W, Suputtamongkol Y, Davis TM, et al. Lack of a significant adverse cardiovascular effect of combined quinine and mefloquine therapy for uncomplicated malaria. Trans R Soc Trop Med Hyg 1997; 91(6):694-696.
22. Winstanley PA, Mberu E,Watkins WM, Murphy SA, Lowe B, Marsh K. Towards optimal parenteral quinine regimens for young children with cerebral malaria: Unbound quinine concentrations following a simple loading dose regimen. Trans R Soc Trop Med Hyg 1994; 88:577-580.
23. Winstanley PA, Newton CR, Watkins WM, et al. Towards optimal parenteral quinine regimens for young children with cerebral malaria: Importance of unbound quinine concentration. Trans Roy Soc Trop Med Hyg 1993; 87: 201-206.
24. Krishna S, Nagajara NV, Planche T, et al. Population pharmacokinetics of intramuscular quinine in children with severe malaria. Antimicrob Agents Chemother 2001; 45(6):1803-1809.
25. Pasvol G, Newton CRJC, Winstanley PA, et al. Quinine treatment of severe falciparum malaria in African children: A randomised comparison of three regimens. Am J Trop Med Hyg 1991; 45:702-713.
26. Artemether-quinine meta-analysis study group. A meta-analysis using individual patient data of trials comparing artemether with quinine in the treatment of severe falciparum malaria. Trans R Soc Trop Med Hyg 2000; 95:637-650.
27. Davis TM, Phuong HL, Ilett KF, et al. Pharmacokinetics and pharmacodynamics of intravenous artesunate in severe falciparum malaria. Antimicrob Agents Chemother 2001; 45(1):181-186.
28. Newton P, Suputtamongkol Y, Teja-Isavadharm P, et al. Antimalarial bioavailability and disposition of artesunate in acute falciparum malaria. Antimicrob Agents Chemother 2000; 44(4):972-977.
29. Nosten F, van Vugt M, White NJ. Intrarectal artemisinin derivatives. Med Trop (Mars) 1998; 58(3 Suppl):63-64.
30. English M. Life-threatening severe malarial anaemia. Trans R Soc Trop Med Hyg 2000; 94(6):585-588.